Kura Oncology, Inc. SEC filings KURA

Kura Oncology, Inc. has 806 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (other events). The company's fiscal year ends on December 31.

Kura Oncology, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 29, 2026 Sep 28, 2026
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 29, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
144 Notice of proposed sale Sep 28, 2026 —
4 Insider transaction Sep 25, 2026 Sep 24, 2026
144 Notice of proposed sale Sep 24, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
3 Initial insider ownership Sep 10, 2026 Sep 8, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Officer or director change
Sep 8, 2026 Sep 8, 2026
4 Insider transaction Aug 24, 2026 Aug 24, 2026
4 Insider transaction Aug 24, 2026 Aug 21, 2026
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 19, 2026 —
4 Insider transaction Aug 17, 2026 Aug 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Officer or director change
Jul 29, 2026 Jul 24, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 18, 2026 —
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
4 Insider transaction Jun 4, 2026 Jun 4, 2026
S-8 Employee stock plan registration Jun 4, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 4, 2026
DEFA14A Additional proxy material May 26, 2026 —
4 Insider transaction May 22, 2026 May 21, 2026
144 Notice of proposed sale May 21, 2026 —
4 Insider transaction May 20, 2026 May 19, 2026
4 Insider transaction May 20, 2026 May 19, 2026
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 19, 2026 —
144 Notice of proposed sale May 19, 2026 —
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 Jun 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 5, 2026 Mar 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 9, 2026 —
8-K Current report
Bylaw or fiscal year change
Jan 29, 2026 Jan 28, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
4 Insider transaction Jan 27, 2026 Jan 27, 2026
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
144 Notice of proposed sale Jan 27, 2026 —
8-K Current report
Results of operations
Jan 12, 2026 Jan 11, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Dec 19, 2025 Dec 18, 2025
144 Notice of proposed sale Dec 18, 2025 —
4 Insider transaction Dec 10, 2025 Dec 9, 2025
144 Notice of proposed sale Dec 9, 2025 —
8-K Current report
Other events
Dec 2, 2025 Dec 2, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
4 Insider transaction Nov 14, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 14, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
4 Insider transaction Nov 14, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 14, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
8-K Current report
Other events
Nov 13, 2025 Nov 13, 2025
S-8 Employee stock plan registration Nov 4, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
8-K Current report
Other events
Oct 24, 2025 Oct 24, 2025
8-K Current report
Other events
Oct 16, 2025 Oct 15, 2025
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 29, 2025 Sep 27, 2025
4 Insider transaction Sep 9, 2025 Sep 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 15, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Material agreement
Jul 1, 2025 Jun 27, 2025
8-K Current report
Other events
Jun 18, 2025 Jun 12, 2025
S-8 Employee stock plan registration Jun 6, 2025 —
4 Insider transaction Jun 6, 2025 Jun 5, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
4 Insider transaction Jun 6, 2025 Jun 5, 2025
8-K Current report
Other events
Jun 3, 2025 Jun 1, 2025
4 Insider transaction May 19, 2025 May 19, 2025
4 Insider transaction May 19, 2025 May 19, 2025
144 Notice of proposed sale May 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 2, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 17, 2025 —
DEFA14A Additional proxy material Apr 11, 2025 —
DEF 14A Proxy statement Apr 11, 2025 Jun 5, 2025
4 Insider transaction Mar 24, 2025 Mar 21, 2025
144 Notice of proposed sale Mar 21, 2025 —
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
8-K Current report
Other events
Feb 5, 2025 Feb 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2025 —
4 Insider transaction Jan 28, 2025 Jan 28, 2025
4 Insider transaction Jan 28, 2025 Jan 28, 2025
4 Insider transaction Jan 28, 2025 Jan 28, 2025
4 Insider transaction Jan 28, 2025 Jan 28, 2025
4 Insider transaction Jan 28, 2025 Jan 28, 2025
4 Insider transaction Jan 28, 2025 Jan 28, 2025
144 Notice of proposed sale Jan 28, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
144 Notice of proposed sale Jan 28, 2025 —
8-K Current report
Material agreement, New debt
Jan 14, 2025 Jan 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2025 —
4 Insider transaction Jan 7, 2025 Jan 2, 2025
3 Initial insider ownership Jan 7, 2025 Jan 2, 2025
4 Insider transaction Jan 7, 2025 Jan 2, 2025
3 Initial insider ownership Jan 7, 2025 Jan 2, 2025
8-K Current report
Officer or director change, Other events
Jan 6, 2025 Jan 1, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
8-K Current report
Other events
Dec 20, 2024 Dec 16, 2024
SC 13G Ownership over 5% (passive) Dec 5, 2024 —
8-K Current report
Material agreement
Nov 20, 2024 Nov 20, 2024
4 Insider transaction Nov 19, 2024 Nov 18, 2024
144 Notice of proposed sale Nov 18, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 17, 2024 Sep 13, 2024
8-K Current report
Officer or director change
Sep 17, 2024 Sep 13, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KURA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1422143
Former names
ZETA ACQUISITION CORP III (until Mar 10, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.